| Company Name: | Memry Corporation | | Ticker Symbol: | MRY | | | WWW Address: | www.memry.com | | CEO: | Robert P. Belcher | | No. of Employees: | 363 | | Common Issue Type: | CS | | Business Description: | The Company is engaged in the business of developing, manufacturing and marketing products and components that are sold to the medical device industry.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 2.51 |  0.0 | - | - | 0 | 2.53 | 2.48 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 75.1 | 29.9 | -0.07 | 0.01 | 0.00 | 83.7 | 0.0 | 2.53 - 0.99 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 2.51 | $ | | PE Ratio - LTM | 83.7 | |
| Market Capitalisation | 75.1 | mil |
| Latest Shares Outstanding | 29.9 | mil |
| Earnings pS (EPS) | 0.01 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 142,361 | $ |
| Effective Tax Rate | 29.4 | % |
| Float | 23.4 | mil |
| Float as % of Shares Outstanding | 78.3 | % |
| Foreign Sales | 11 | mil |
| Domestic Sales | 41 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 24.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 4.00 | % |
| Gross Profit Margin | 37.8 | % |
| EBITDA Margin | 9.1 | % |
| Pre-Tax Profit Margin | 2.6 | % |
| Assets Turnover | 1.1 | % |
| Return on Assets (ROA) | 1.7 | % |
| Return on Equity (ROE) | 1.9 | % |
| Return on Capital Invested (ROCI) | 1.9 | % |
| Current Ratio | 2.8 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 10.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.02 | |
| LT Debt/Total Capital | 1.0 | % |
| Working Capital pS | 0.40 | $ |
| Cash pS | 0.15 | $ |
| Book-Value pS | 1.43 | $ |
| Tangible Book-Value pS | 0.75 | $ |
| Cash Flow pS | 0.14 | $ |
| Free Cash Flow pS | 0.13 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.76 | |
| Price/Tangible Book Ratio | 3.35 | |
| Price/Cash Flow | 17.9 | |
| Price/Free Cash Flow | 19.3 | |
| P/E as % of Industry Group | 404.0 | % |
| P/E as % of Sector Segment | 239.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.4 | 110 | 1,698 | 3,182 |
| 4 Weeks | 2.53 | 2.43 | 2.51 | 0.0 | 112 | 1,243 | 19,882 |
| 13 Weeks | 2.53 | 2.38 | 2.39 | 5.0 | 120 | 1,297 | 77,835 |
| 26 Weeks | 2.53 | 0.99 | 1.03 | 143.7 | 302 | 1,383 | 170,136 |
| 52 Weeks | 2.53 | 0.99 | 1.73 | 45.1 | 204 | 858 | 211,865 |
| YTD | 2.53 | 0.99 | - | 100.8 | 266 | 1,006 | 189,085 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 2.51 | 2.51 | 2.48 | 1.83 | 1.69 | -0.07 | -1.04 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 10.71 | 84.5 | 6.48 |
| Income | -42.47 | 73.2 | -44.48 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 31.67 | NA | 19.15 |
| R&D | 0.00 | NA | -8.51 |
| Normalized Inc. | -36.55 | NA | -38.77 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 7.1 | 11.6 | -1.7 |
| Earnings % | 184.0 | 0.0 | -88.1 |
| EPS % | 200.0 | 0.0 | -88.9 |
| EPS $ | 0.02 | 0.03 | -0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 21.00 |
| Current Ratio | 2.5 |
| Quick Ratio (Acid Test) | 1.3 |
| Liquidity Ratio (Cash) | 0.36 |
| Receivables Turnover | 7.1 |
| Average Collection Period | 51 |
| Working Capital/Equity | 24.8 |
| Working Capital pS | 0.34 |
| Cash-Flow pS | 0.12 |
| Free Cash-Flow pS | 0.10 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 7.55 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 15.2 |
| Total Debt/Equity (Gearing Ratio) | 0.04 |
| LT Debt/Equity | 0.02 |
| LT Debt/Capital Invested | 1.8 |
| LT Debt/Total Liabilities | 8.7 |
| Interest Cover | 1.5 |
| Interest/Capital Invested | 2.31 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.59 |
| Tobin's Q Ratio | 1.54 |
| Current P/E Ratio - LTM | 83.70 |
| Enterprise Value (EV)/EBITDA | 18.21 |
| Enterprise Value (EV)/Free Cash Flow | 40.38 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.35 |
| Price/Book Ratio - LTM | 1.76 |
| Price/Cash Flow Ratio | 17.9 |
| Price/Free Cash Flow Ratio - LTM | 19.3 |
| Price/Sales Ratio | 1.38 |
| P/E Ratio (1 month ago) - LTM | 83.3 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 57.7 |
| 5-Y High P/E Ratio | 331.0 |
| 5-Y Low P/E Ratio | 2.3 |
| 5-Y Average P/E Ratio | 47.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 175 |
| P/E as % of Industry Group | 404.0 |
| P/E as % of Sector Segment | 239.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 83.7 |
| PER SHARE FIGURES |
| LT Debt pS | 0.02 |
| Current Liabilities pS | 0.22 |
| Tangible Book Value pS - LTM | 0.75 |
| Book Value pS - LTM | 1.43 |
| Capital Invested pS | 1.40 |
| Cash pS - LTM | 0.15 |
| Cash Flow pS - LTM | 0.14 |
| Free Cash Flow pS - LTM | 0.13 |
| Earnings pS (EPS) | 0.01 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.96 |
| Free Cash Flow Margin 5YEAR AVG | 2.08 |
| Net Profit Margin | 0.6 |
| Net Profit Margin - 5YEAR AVRG. | 7.8 |
| Equity Productivity | 1.25 |
| Return on Equity (ROE) | 0.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 9.9 |
| Capital Invested Productivity | 1.23 |
| Return on Capital Invested (ROCI) | 0.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 8.9 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | 0.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.7 |
| Gross Profit Margin | 37.8 |
| Gross Profit Margin - 5YEAR AVRG. | 41.7 |
| EBITDA Margin - LTM | 9.1 |
| EBIT Margin - LTM | 2.8 |
| Pre-Tax Profit Margin | 0.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 6.6 |
| Effective Tax Rate | 29.4 |
| Effective Tax Rate - 5YEAR AVRG. | -38.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 109 |
| Revenue per Employee | 142,361 |
| Net Income per Employee | 873 |
| Average Collection Period | 44 |
| Receivables Turnover | 7.1 |
| Day's Inventory Turnover Ratio | 65 |
| Inventory Turnover | 5.6 |
| Inventory/Sales | 12.1 |
| Accounts Payble/Sales | 5.78 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | 5.05 |
| Fixed Assets Turnover | 1.62 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 21.52 |
| Revenue per $ Plant | 5.86 |
| Revenue per $ Common Equity | 1.25 |
| Revenue per $ Capital Invested | 1.23 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 25.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 23.8 |
| Research & Devlopment (R&D) as % of Revenue | 3.2 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 3.2 |
|
|  
|
| |
 |  |